Abstract:Sjögren’s syndrome (SS) is a chronic autoimmune disease of unknown etiology that mainly involves exocrine glands. Patients present with dry mouth and eyes, fever, arthralgia, and other systemic symptoms. In severe cases, the quality of life of patients is affected. At present, there is no cure for SS, and the treatment options are extremely limited. In recent years, studies of patients and animal models have identified abnormalities of immune cell function and cytokines to be involved in SS. A systematic review of the literature may clarify the etiology and pathogenesis of SS, as well as provide a theoretical basis for the development of new drugs for the treatment of SS.

What problem does this paper attempt to address?

This paper primarily reviews the latest advances in the pathogenesis of Sjögren's syndrome (SS). SS is a chronic autoimmune disease of unknown etiology that primarily affects exocrine glands, with patients often presenting symptoms such as dry mouth and dry eyes, which can severely impact quality of life. Currently, there is no cure for SS, and treatment options are very limited. The paper explores the pathogenesis of SS from the following aspects: 1. **Genetic Susceptibility**: Genome-wide association studies have identified several risk loci and susceptibility genes related to SS, such as IRF5-TNPO3 and STAT4. In female patients, GTF2I and RBMS3 are considered important susceptibility genes. Additionally, the abnormal expression of long non-coding RNA (lncRNA) and microRNA (miRNA) is also associated with the development and progression of SS. 2. **Infectious Factors**: Viral infections are believed to play a significant role in the development of SS, including Epstein-Barr virus (EBV) and human T-lymphotropic virus type 1 (HTLV-1). These viral infections may contribute to the disease process by altering the biological characteristics of epithelial cells or triggering abnormal immune responses. 3. **Dysfunction of Salivary Gland Epithelial Cells**: Salivary gland epithelial cells (SGECs) play a crucial role in the initiation and propagation of the immune response in SS. SGECs can secrete pro-inflammatory factors and act as antigen-presenting cells to induce T lymphocyte differentiation, thereby participating in the immune damage process. 4. **Role of Immune Cells**: - Overactivation of B cells leads to the production of autoantibodies and swelling of exocrine glands. - Imbalance of T cells, especially Th17 cells and regulatory T cells (Tregs), also plays a significant role in SS. - Dendritic cells (DCs) promote inflammatory responses by presenting antigens to T lymphocytes. 5. **Role of Cytokines**: Various cytokines such as IL-1, IL-17, and IFN-α play key roles in the inflammatory process of SS. 6. **Neuroendocrine Factors**: A decline in estrogen levels may be related to the onset of SS, particularly more pronounced in postmenopausal women. In summary, this review paper provides a detailed introduction to the research progress on the pathogenesis of SS in recent years, covering multiple aspects such as genetics, infection, immune cell dysfunction, cytokines, and neuroendocrine factors. It offers a comprehensive perspective for understanding the complexity of SS and lays a theoretical foundation for further exploration of treatment methods.

Advances in Pathogenesis of Sjögren’s Syndrome

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Biomarkers for Primary Sjögren’s Syndrome

Pathogenesis and diagnostic and therapeutic characteristics of Sjogren's syndrome based on TCM theory of five zang-organs

Mesenchymal Stem Cells in Primary Sjögren's Syndrome: Prospective and Challenges

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjogren's syndrome

Pathogenesis and treatment of Sjogren's syndrome: Review and update

Advances in cellular and molecular pathways of salivary gland damage in Sjögren's syndrome

Exploiting the role of T cells in the pathogenesis of Sjögren's syndrome for therapeutic treatment

A comprehensive review of Sjögren's syndrome: Classification criteria, risk factors, and signaling pathways

Immunobiology of T Cells in Sjögren’s Syndrome

Composition and Regulation of the Immune Microenvironment of Salivary Gland in Sjögren’s Syndrome

Composition and Regulation of Immune Microenvironment of Salivary Gland in Sjögren's Syndrome

Update on the pathophysiology and treatment of primary Sjögren syndrome

Treatment progress of primary sj(o)gren's syndrome

Cell therapy in Sjögren's syndrome: opportunities and challenges

Mechanisms and New Strategies for Primary Sjögren's Syndrome

How to treat Sjögren's syndrome

Abnormal Epigenetic Regulations in the Immunocytes of Sjögren's Syndrome Patients and Therapeutic Potentials

Impact of sex differences on the clinical presentation, pathogenesis, treatment and prognosis of Sjögren's syndrome